Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodial transport proteins are a diverse set of membrane-resident or -associated molecules found in malaria parasites, especially Plasmodium falciparum. They are essential for parasite survival, mediating the import of nutrients, export of waste, and maintenance of ionic homeostasis. Many lack human orthologs, increasing their attractiveness as drug targets. This includes specific well-studied proteins such as the chloroquine resistance transporter (PfCRT), ATP-binding cassette (ABC) transporters (e.g., PfMDR, PfMRP), cation ATPases (PfATP4), and others. These proteins also contribute to drug resistance and are the focus of ongoing antimalarial drug development efforts. Inhibition of these transporters frequently causes fatal disruptions to parasite physiology.
Inhibition or modulation of transporter activity, leading to disruption of ion homeostasis, nutrient uptake, or membrane potential (often resulting in parasite death or reduced viability)
15 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodial transport protein (None universally established; individual proteins have specific gene or protein abbreviations (e.g., PfCRT, PfATP4). For the group, use the full name.).